Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2d4209be4895e6bdc176088857fec242 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c218f9a7f231eb98305c1ecbf809d644 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_402b1877c42298a84b461961e3aea671 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55511 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55572 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-55555 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-57 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6093 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2710-16134 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5153 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-245 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1647 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 |
filingDate |
2011-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_201e9dc0e87b7b1528c5b30c0a9d5e3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d60ba61f559a2b410e72c759b3f93a13 |
publicationDate |
2011-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2011153532-A1 |
titleOfInvention |
Peptide particle formulation |
abstract |
A composition as disclosed is comprised of a plurality of groups of particles. The particles are comprised of a biocompatible polymer which maybe a co-polymer such as PLGA combined with a peptide of a sequence of interest, e.g. a sequence which corresponds to a sequence presented on a surface of a cell infected with a virus. A plurality of different groups of particles are provided in the formulation wherein the particles within any single group include peptides of identical amino acid sequence. The particles are sized such that they are sufficiently large so as to prevent more than the contents of a single particle from being presented to a single immune system cell. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11045492-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10471093-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11129881-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2683388-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11413337-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10201596-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11160851-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9616113-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10188711-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11389517-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9522180-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9913883-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11020424-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10617747-B2 |
priorityDate |
2010-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |